BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2253927)

  • 1. The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial.
    Xiao SD; Liu WZ; Xia DH; Jiang SJ; Wang RN; Zhang ZH; Xu WW
    Hepatogastroenterology; 1990 Oct; 37(5):503-6. PubMed ID: 2253927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
    Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
    Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
    J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
    Kyzekové J; Arlt J; Arltová M
    Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of eradication therapy in patients with chronic atrophic gastritis and seropositivity for anti-HP antibodies and histological negativity for Helicobacter pylori].
    Leri O; Mastropasqua M; Scopelliti G; Grasso E; Losi T; Iadicicco A; Perinelli P
    Clin Ter; 1999; 150(5):343-6. PubMed ID: 10687264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.
    Ozdemir A; Mas MR; Sahin S; Sağlamkaya U; Ateşkan U
    Quintessence Int; 2001 Feb; 32(2):131-4. PubMed ID: 12066673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
    Gisbert JP; Boixeda D; Alvarez Baleriola I; Redondo C; De Rafael L; Martín de Argila C; Hernández Ranz F
    Rev Esp Enferm Dig; 1995 Apr; 87(4):281-7. PubMed ID: 7794634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
    Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
    Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis.
    Hsu PI; Lai KH; Chien EJ; Lin CK; Lo GH; Jou HS; Cheng JS; Chan HH; Hsu JH; Ger LP; Hsu PN; Tseng HH
    Anticancer Res; 2000; 20(2B):1221-8. PubMed ID: 10810425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
    Bianchi Porro G; Lazzaroni M; Bargiggia S; Maconi G; Trespi E; Perego M; Alvisi C; Villani L; Luinetti O; Fiocca R; Franceschi M; Cesana B; Solcia E
    Am J Gastroenterol; 1996 Apr; 91(4):695-700. PubMed ID: 8677931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misoprostol for the treatment of chronic erosive gastritis: a double-blind placebo-controlled trial.
    Pazzi P; Gamberini S; Scagliarini R; Dalla Libera M; Merighi A; Gullini S
    Am J Gastroenterol; 1994 Jul; 89(7):1007-13. PubMed ID: 8017357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori acute gastritis: histological, endoscopical, clinical, and therapeutic features.
    Rocha GA; Queiroz DM; Mendes EN; Barbosa AJ; Lima Júnior GF; Oliveira CA
    Am J Gastroenterol; 1991 Nov; 86(11):1592-5. PubMed ID: 1951235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six-month, follow-up study.
    Milutinovic AS; Todorovic V; Milosavljevic T; Micev M; Spuran M; Drndarevic N
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):755-66. PubMed ID: 12811306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
    Zhou L; Sung JJ; Lin S; Jin Z; Ding S; Huang X; Xia Z; Guo H; Liu J; Chao W
    Chin Med J (Engl); 2003 Jan; 116(1):11-4. PubMed ID: 12667379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial effectiveness of furazolidone against metronidazole-resistant strains of Helicobacter pylori.
    Safaralizadeh R; Siavoshi F; Malekzadeh R; Akbari MR; Derakhshan MH; Sohrabi MR; Massarrat S
    East Mediterr Health J; 2006; 12(3-4):286-93. PubMed ID: 17037696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
    Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Martín de Argila C
    Gastroenterol Hepatol; 2000; 23(6):269-74. PubMed ID: 15324621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.